HYPEX INTERNATIONAL PTE. LTD.
UEN: 200405230C
HYPEX INTERNATIONAL PTE. LTD.(200405230C) is a Singapore business with registered business address at 132 GUL CIRCLE, Singapore 629597. They specialise in the area of BUILDING CONSTRUCTION N.E.C. and BUILDING AND REPAIRING OF SHIPS, TANKERS AND OTHER OCEAN-GOING VESSELS (INCLUDING CONVERSION OF SHIPS INTO OFF-SHORE STRUCTURES).
| Company Name | HYPEX INTERNATIONAL PTE. LTD. |
| Unique Entity Number | 200405230C |
| Entity Type | Local Company |
| Entity Status | Live Company |
| Incorporate Day | 29 April 2004 |
| Address |
132 GUL CIRCLE Singapore 629597 |
| Products / Services |
BUILDING CONSTRUCTION N.E.C. BUILDING AND REPAIRING OF SHIPS, TANKERS AND OTHER OCEAN-GOING VESSELS (INCLUDING CONVERSION OF SHIPS INTO OFF-SHORE STRUCTURES) |
| Number of Officers | 6 |
| Paid Up Capital | SGD 1172006 |
Breaking! Business News
Bombardier Releases its 2019 Activity Report, Highlighting Sustainability Milestones and ObjectivesBombardier Releases its 2019 Activity Report, Highlighting Sustainability Milestones and ObjectivesG...
Read More
International Spirits & Wellness Holdings Enters Joint-Venture Agreement with Official Distributor of Top-Selling Crypto Mining EquipmentInternational Spirits & Wellness Holdings Enters Joint-Venture Agreement with Official Distributor o...
Read More
Zoom Hires Damien Hooper-Campbell as Chief Diversity OfficerZoom Hires Damien Hooper-Campbell as Chief Diversity OfficerTech Industry Veteran to Lead Expansion ...
Read More
Wasabi Builds on Explosive Growth with $30 Million Funding RoundWasabi Builds on Explosive Growth with $30 Million Funding RoundNew investment to drive Wasabi’s g...
Read More
Virtusa to Increase Speed, Reduce Costs of Critical Digital Transformation InitiativesVirtusa to Increase Speed, Reduce Costs of Critical Digital Transformation InitiativesNew Digital Tr...
Read More
Philips Foundation publishes its 2019 Annual Report Philips Foundation publishes its 2019 Annual Report GlobeNewswireMay 28, 2020May 28, 2020 ...
Read More
Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II StudyAtriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II StudyGlob...
Read More
Capgemini Press Release // Capgemini and Audi launch new Joint Venture: XL2Capgemini Press Release // Capgemini and Audi launch new Joint Venture: XL2GlobeNewswireMay 28, 2020...
Read More